Amr Edrees is a Rheumatology/Immunology physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 23 publications with 410 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 Holmes St
Kansas City, MO 641082640
Telephone
816-404-1075Provider last certified this registry record 30 Nov 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Cardinal Health 110 LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
29.1%Folate Analog Metabolic Inhibitor13.7%Methotrexate89%Rasuvo7%Methotrexate Sodium4%Part D<11 patientsTNF inhibitor8.4%Enbrel Sureclick43%Humira(Cf) Pen42%Humira(Cf)9%Simponi3%Humira Pen3%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
19.8%Corticosteroid10.4%Prednisone100%Part D≥108 patientsAminosalicylate3.4%Sulfasalazine51%Sulfasalazine Dr49%Part D≥19 patients+ 7 more classes in this area
Cardiovascular
14.5%Statin3.9%Atorvastatin Calcium89%Rosuvastatin Calcium11%Part D<11 patientsCalcium channel blocker3.4%Amlodipine Besylate100%Part D≥43 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Case Report: Severe Legionnaires' Disease Complicated by Rhabdomyolysis and Acute Kidney Injury in a Patient With Rheumatoid Arthritis
International Journal of Rheumatic Diseases
2025 - TNF inhibitor treating osseous sarcoidosis and dactylitis: case and literature review
Clinical Rheumatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
John Spertus, MD
University of Missouri–Kansas City
Barry Rutherford, MD
University of Missouri–Kansas City
Lamont Weide, MD, PhD, FACE
University of Missouri–Kansas City
Jill Moormeier, MD
University of Missouri–Kansas City
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”